(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Effect of Shh on regeneration. Inhibition of the Shh pathway using KAAD
increases the domain of transdifferentiation (A-C,J-L,S-U) compared to eyes
that received Fgf2 alone (D-F,M-O,V-X). However, overexpression of Shh using
Rcas-Shh decreases transdifferentiation (G-I,P-R,Y,Z). (A-I) E7. (A) At E7,
KAAD/Fgf2-treated eyes show regeneration from the CB/CMZ (cr) as well the
transdifferentiation of RPE (td). (B) A close up view of CB/CMZ from an E7
KAAD/Fgf2-treated eye. (C) A close up view of transdifferentiation from an E7
KAAD/Fgf2-treated eye. (D) Regenerating eye that has been treated with Fgf2
only. (E) A close up view of CB/CMZ regenerated retina. (F) Close up view of
transdifferentiated retina. (G) Regenerating eye that has been treated with
Rcas-Shh/Fgf2 shows almost no transdifferentiation. (H) CB/CMZ regenerated
retina, where Shh has been overexpressed does not look different from that of
E7 Fgf2-treated regenerating neuroepithelium (E). (I) Occasionally, there are
small areas of transdifferentiation in the regenerating eyes that received
Rcas/Shh/Fgf2. The neuroepithelium at this stage is similar to that of an
Fgf2-treated transdifferentiating retina (F). (J-R) E11. (J) At E11,
KAAD/Fgf2-treated eyes show an increased domain of transdifferentiation when
compared to Fgf2-treated eyes of the same stage (M). (P) At this stage,
several eyes that overexpress Shh show some transdifferentiation. KAAD/Fgf2
and Fgf2-treated eyes show similar organization having a GCL, IPL and INL
(K,L,N,O); whereas Rcas-Shh/Fgf2-treated eyes seem to be more differentiated
with a visible OPL and ONL (Q,R). (S-Z) E15. (S) At E15, most of the retina in
KAAD/Fgf2-treated eyes results from transdifferentiation. However, there exist
small regions that contain CB/CMZ regenerated retina. (V) Eyes treated with
Fgf2 show both transdifferentiated retina and CB/CMZ regenerated retina. (Y)
Rcas-Shh/Fgf2-treated eyes do not show any transdifferentiated retina and all
the retina present is produced by regeneration from the CB/CMZ. All the
retinas at this stage show similar levels of spatial organization (T,U,W,X,Z).
Scale bars: 500 µm (A,D,G,J,M,S); 100 µm and is applicable to
B,C,E,F,H,I,K,L,N,O,Q,R,T,U,W,X,Z; in P is 500 µm and applies to Y; 500
µm (V). An asterisk marks an Fgf2-coated heparin bead.